Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar - PubMed (original) (raw)

Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar

B Rasoamanana et al. Clin Diagn Lab Immunol. 1997 Sep.

Abstract

Bacteriological isolation of Yersinia pestis is the reference test for confirming plague infection, but recovery of the pathogen from human samples is usually very poor. When the etiology of the disease cannot be bacteriologically confirmed, it may be useful to possess alternative tests such as detection of specific circulating antibodies to help guide the diagnosis. In the present study, the immunoglobulin G (IgG) anti-F1 enzyme-linked immunosorbent assay (ELISA) has been applied to various human sera to evaluate its large-scale applicability in the high-endemicity plague foci of Madagascar. The sensitivity of the test was found to be 91.4%, and its specificity was 98.5%. The positive and negative predictive values were 96 and 96.6%, respectively. Seroconversion was observed on day 7 after onset of the disease. Patients with a positive ELISA result could be separated into high (82%) and low (18%) IgG anti-F1 responders. Cross-reactions with eight other infectious diseases prevalent in Madagascar were scarce and were found in 1 of 27 Mycobacterium tuberculosis-, 3 of 34 Schistosoma haematobium-, and 1 of 41 Salmonella-infected patients. Finally, the efficiency of the IgG anti-F1 ELISA was evaluated during the Mahajanga, Madagascar, plague outbreak of 1995. When the number of ELISA-positive patients was added to the number of bacteriologically confirmed and probable cases, the number of positive patients was increased by 35%. In conclusion, although it does not replace bacteriology, IgG anti-F1 ELISA is a useful and powerful tool for retrospective diagnosis and epidemiological surveillance of plague outbreaks.

PubMed Disclaimer

Similar articles

• Short report: Serodiagnosis of plague in humans and rats using a rapid test.
  Thullier P, Guglielmo V, Rajerison M, Chanteau S. Thullier P, et al. Am J Trop Med Hyg. 2003 Oct;69(4):450-1. Am J Trop Med Hyg. 2003. PMID: 14640508
• [Seroepidemiologic study of human plague in Madagascar].
  Leroy F. Leroy F. Ann Biol Clin (Paris). 1997 Jul-Aug;55(4):332-6. Ann Biol Clin (Paris). 1997. PMID: 9309233 French.
• Short- and long-term humoral immune response against Yersinia pestis in plague patients, Madagascar.
  Andrianaivoarimanana V, Iharisoa AL, Rahalison L, Ralimanantsoa ML, Ratsitorahina M, Rakotonanahary RJL, Carniel E, Demeure C, Rajerison M. Andrianaivoarimanana V, et al. BMC Infect Dis. 2020 Nov 10;20(1):822. doi: 10.1186/s12879-020-05565-8. BMC Infect Dis. 2020. PMID: 33172393 Free PMC article.
• Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick.
  Chanteau S, Rahalison L, Ratsitorahina M, Mahafaly, Rasolomaharo M, Boisier P, O'Brien T, Aldrich J, Keleher A, Morgan C, Burans J. Chanteau S, et al. Int J Med Microbiol. 2000 Jul;290(3):279-83. doi: 10.1016/S1438-4221(00)80126-5. Int J Med Microbiol. 2000. PMID: 10959730 Clinical Trial.
• Evaluation of three serological tests for the detection of human plague in northeast Brazil.
  de Almeida AM, Ferreira LC. de Almeida AM, et al. Mem Inst Oswaldo Cruz. 1992 Jan-Mar;87(1):87-92. doi: 10.1590/s0074-02761992000100014. Mem Inst Oswaldo Cruz. 1992. PMID: 1308559

Cited by

• Pneumonic plague outbreak, Northern Madagascar, 2011.
  Richard V, Riehm JM, Herindrainy P, Soanandrasana R, Ratsitoharina M, Rakotomanana F, Andrianalimanana S, Scholz HC, Rajerison M. Richard V, et al. Emerg Infect Dis. 2015 Jan;21(1):8-15. doi: 10.3201/eid2101.131828. Emerg Infect Dis. 2015. PMID: 25530466 Free PMC article.
• Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.
  Li B, Du C, Zhou L, Bi Y, Wang X, Wen L, Guo Z, Song Z, Yang R. Li B, et al. Clin Vaccine Immunol. 2012 Feb;19(2):228-34. doi: 10.1128/CVI.05559-11. Epub 2011 Dec 21. Clin Vaccine Immunol. 2012. PMID: 22190397 Free PMC article.
• Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.
  Andrianaivoarimanana V, Bertherat E, Rajaonarison R, Rakotondramaro T, Rogier C, Rajerison M. Andrianaivoarimanana V, et al. BMC Pulm Med. 2018 May 29;18(1):92. doi: 10.1186/s12890-018-0656-y. BMC Pulm Med. 2018. PMID: 29843675 Free PMC article.
• Immunogenetics, sylvatic plague and its vectors: insights from the pathogen reservoir Mastomys natalensis in Tanzania.
  Haikukutu L, Lyaku JR, Lyimo CM, Eiseb SJ, Makundi RH, Olayemi A, Wilhelm K, Müller-Klein N, Schmid DW, Fleischer R, Sommer S. Haikukutu L, et al. Immunogenetics. 2023 Dec;75(6):517-530. doi: 10.1007/s00251-023-01323-7. Epub 2023 Oct 19. Immunogenetics. 2023. PMID: 37853246 Free PMC article.
• Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak.
  Andrianaivoarimanana V, Wagner DM, Birdsell DN, Nikolay B, Rakotoarimanana F, Randriantseheno LN, Vogler AJ, Sahl JW, Hall CM, Somprasong N, Cauchemez S, Schweizer HP, Razafimandimby H, Rogier C, Rajerison M. Andrianaivoarimanana V, et al. Clin Infect Dis. 2022 Mar 1;74(4):695-702. doi: 10.1093/cid/ciab606. Clin Infect Dis. 2022. PMID: 34244722 Free PMC article.

References

1. 1. Bull World Health Organ. 1982;60(5):777-81 - PubMed
2. 1. Presse Med. 1996 Nov 9;25(34):1627-30 - PubMed
3. 1. Sante. 1997 Jan-Feb;7(1):53-60 - PubMed
4. 1. Bull World Health Organ. 1966;34(6):911-8 - PubMed
5. 1. Bull World Health Organ. 1970;42(3):451-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information